Journal:
:iranian journal of pharmaceutical research
0
yunes panahi chemical injuries research center, baqiyatallah medical sciences university, tehran, iran.
mojtaba mojtahedzadeh pharmaceutical research center, tehran university of medical sciences, tehran, iran.
faculty of pharmacy, tehran university of medical sciences, tehran, iran.
nuria zekeri faculty of pharmacy, tehran university of medical sciences, tehran, iran.
fatemeh beiraghdar nephrology and urology research center, baqiyatallah medical sciences university, tehran, iran.
mohammad-reza khajavi icu, sina hospital, tehran university of medical sciences, tehran, iran
arezo ahmadi trauma research center, tehran university of medical sciences, tehran, iran.
new-onset hyperglycemia in patients admitted to intensive care units increases the risk of morbidity and mortality. insulin resistance is frequently seen in the treatment of stress-induced hyperglycemia. metformin, an oral anti-hyperglycemic agent, may introduce a new treatment protocol in critically ill patients with insulin-resistance hyperglycemia. fifty-one non-diabetic traumatized patients...